Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes

European Heart Journal

Volumn 36, Issue 17, 2015, Pages 1041-1048

  Klingenberg, Roland ^a,b   Brokopp, Chad E ^c   Grivès, Audrey ^d   Courtier, Anaïs ^d   Jaguszewski, Milosz ^a   Pasqual, Nicolas ^d   Vlaskou Badra, Eugenia ^a   Lewandowski, Anika ^a   Gaemperli, Oliver ^a   Hoerstrup, Simon P ^c   Maier, Willibald ^a   Landmesser, Ulf ^a,b   Lüscher, Thomas F ^a,b   Matter, Christian M ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d ImmunID Technologies   (France)

Author keywords

Acute coronary syndromes; Immunity; T cells

Indexed keywords

GENOMIC DNA; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIAC PATIENT; CD25+ T LYMPHOCYTE; CD27+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); CLONAL RESTRICTION; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DNA EXTRACTION; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE GENE; IMMUNOGENETICS; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL RECEPTOR BETA J GENE; T CELL RECEPTOR BETA V GENE; T LYMPHOCYTE SUBPOPULATION; AGED; CLINICAL TRIAL; HEART INFARCTION; IMMUNOLOGY; LYMPHOCYTOSIS; MONONUCLEAR CELL;

ACUTE CORONARY SYNDROME; ADULT; AGED; CORONARY THROMBOSIS; FLOW CYTOMETRY; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, REGULATORY;

EID: 84928392778     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht543     Document Type: Article

References (36)

1. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-C18
2. Crea F, Liuzzo G. Pathogenesis of acute coronary syndromes. J Am Coll Cardiol 2013; 61: 1-11
3. Libby P.Mechanisms of acute coronary syndromesand their implications for therapy. N Engl J Med 2013; 368: 2004-2013
4. WyssCA, Neidhart M, Altwegg L, Spanaus KS, YonekawaK, Wischnewsky MB, Corti R, Kucher N, RoffiM, Eberli FR, Amann-Vesti B, GayS, vonEckardstein A, Luscher TF, MaierW. Cellular actors, toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J 2010; 31: 1457-1469
5. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17: 1410-1422
6. Bjorkbacka H, Fredrikson GN, Nilsson J. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis-A review of the experimental evidence. Atherosclerosis 2013; 227: 9-17
7. Klingenberg R, Hansson GK. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009; 30: 2838-2844
8. Lahoute C, Herbin O, Mallat Z, Tedgui A. Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol 2011; 8: 348-358
9. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12: 178-180
10. Klingenberg R, GerdesN, Badeau RM, Gistera A, Strodthoff D, Ketelhuth DF, Lundberg AM, Rudling M, Nilsson SK, Olivecrona G, Zoller S, Lohmann C, Luscher TF, Jauhiainen M, Sparwasser T, Hansson GK. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013; 123: 1323-1334
11. Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, Rudling M, Ketelhuth DF, Gerdes N, Holmgren J, Nilsson J, Hansson GK. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 946-952
12. Wigren M, Kolbus D, Duner P, Ljungcrantz I, Soderberg I, Bjorkbacka H, Fredrikson GN, Nilsson J. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med 2011; 269: 546-556
13. Herbin O, Ait-Oufella H, Yu W, Fredrikson GN, Aubier B, Perez N, Barateau V, Nilsson J, Tedgui A, Mallat Z. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012; 32: 605-612
14. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2007; 2: e779
15. Mor A, Luboshits G, Planer D, Keren G, George J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006; 27: 2530-2537
16. Han SF, Liu P, ZhangW, Bu L, Shen M, Li H, Fan YH, ChengK, ChengHX, Li CX, Jia GL. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol 2007; 124: 90-97
17. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127: 89-97
18. Ammirati E, Cianflone D, Banfi M, Vecchio V, Palini A, De Metrio M, Marenzi G, Panciroli C, Tumminello G, Anzuini A, Palloshi A, Grigore L, Garlaschelli K, Tramontana S, Tavano D, Airoldi F, Manfredi AA, Catapano AL, Norata GD. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 1832-1841
19. Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004; 4: 123-132
20. Pasqual N, Gallagher M, Aude-Garcia C, Loiodice M, Thuderoz F, Demongeot J, Ceredig R, Marche PN, Jouvin-Marche E. Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire. J Exp Med 2002; 196: 1163-1173
21. Venet F, Filipe-Santos O, Lepape A, Malcus C, Poitevin-Later F, Grives A, Plantier N, Pasqual N, Monneret G. Decreased T-cell repertoire diversity in sepsis: a preliminary study. Crit Care Med 2013; 41: 111-119
22. Stemme S, Rymo L, Hansson GK. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest 1991; 65: 654-660
23. Oksenberg JR, Stavri GT, Jeong MC, Garovoy N, Salisbury JR, Erusalimsky JD. Analysis of the T-cell receptor repertoire in human atherosclerosis. Cardiovasc Res 1997; 36: 256-267
24. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, HolmesDR, Frye RL, WeyandCM.Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-2888
25. De Palma R, Del Galdo F, Abbate G, Chiariello M, Calabro R, Forte L, Cimmino G, Papa MF, Russo MG, Ambrosio G, Giombolini C, Tritto I, Notaristefano S, Berrino L, Rossi F, Golino P. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 2006; 113: 640-646
26. Rossmann A, Henderson B, Heidecker B, Seiler R, Fraedrich G, Singh M, ParsonW, Keller M, Grubeck-Loebenstein B, Wick G. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp Gerontol 2008; 43: 229-237
27. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606
28. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
29. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567
30. Vlaar PJ, DiercksGF, SvilaasT, Vogelzang M, de Smet BJ, van den HeuvelAF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. The feasibility and safety of routine thrombus aspiration in patients with non-ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2008; 72: 937-942
31. ManuelM, TredanO, BachelotT, Clapisson G, Courtier A, Parmentier G, RabeonyT, Grives A, Perez S, Mouret JF, Perol D, Chabaud S, Ray-Coquard I, Labidi-Galy I, Heudel P, Pierga JY, Caux C, Blay JY, Pasqual N, Menetrier-Caux C. Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. Oncoimmunology 2012; 1: 432-440
32. Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, Sutsch G, Roffi M, Neidhart M, Eberli FR, Tanner FC, Gobbi S, von Eckardstein A, Luscher TF. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005; 111: 1355-1361
33. Altwegg LA, Neidhart M, Hersberger M, Muller S, Eberli FR, Corti R, Roffi M, Sutsch G, Gay S, von Eckardstein A, Wischnewsky MB, Luscher TF, Maier W. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 2007; 28: 941-948
34. Caligiuri G, Nicoletti A. Tregs and human atherothrombotic diseases: toward a clinical application? Arterioscler Thromb Vasc Biol 2010; 30: 1679-1681
35. Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol 2013; 14: 1007-1013
36. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 95: 14447-14452